STABL.ST

Stayble Therapeutics AB (publ) [STABL.ST] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

STABL.ST Stock Summary

Top 10 Correlated Stocks

STABL.ST

In the News

STABL.ST Financial details

Company Rating
-
Market Cap
7.49M
Income
-22.25M
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
3
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
-0.5
Forward P/E
-
PEG
-0.18
P/S
-
P/B
0.49
P/C
-
P/FCF
-0.48
Quick Ratio
3.88
Current Ratio
4.28
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-1.09
EPS next Y
-
EPS next Q
-
EPS this Y
100%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-15.38%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-76%
ROE
-113%
ROC
-0.94%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.214-6.42
52W High
-
52W Low
-
RSI
45
Rel Volume
0.14
Avg Volume
192.89K
Volume
26.37K
Perf Week
-9.84%
Perf Month
-8.71%
Perf Quarter
-44.3%
Perf Half Y
-32.31%
-
-
-
-
Beta
-0.072
-
-
Volatility
0.01%, 0.05%
Prev Close
0%
Price
0.44
Change
1.85%

Something similar

Top by Market Cap
1YD.DE
META
EMBASSY.NS
ABEC.DE
VOO
Same Sector
UHS
MLC.IR
216080.KQ
RCEL
0RDB.L
Top Correlated Stocks
POW.L
4564.TW
OPG.L
0497.HK
0346.HK
Similar Market Cap
CMX.L
CEAD
COTN.L
NWT.L
BLOE.L

Company Profile

Healthcare Biotechnology
  • Volume Average 192.89K
  • Market Capitalization 7.49M
  • Employee 3
  • CEO Mr. Andreas Gerward M.Sc.
  • Headquarters Gothenburg,SE
  • IPO Date 2020-03-09
  • Website https://www.staybletherapeutics.se

Stayble Therapeutics AB (publ) develops injectable treatment for chronic low back pain triggered by disc degeneration. The company develops STA363, a minimally invasive single injection of the drug into the disc that targets chronic low back pain. Stayble Therapeutics AB (publ) was incorporated in 2015 and is based in Gothenburg, Sweden.